Disease site matters: Ovarian carcinosarcoma has far more genomic similarity to high-grade serous ovarian carcinoma than to uterine carcinosarcoma

被引：0
|
作者：
Walker, Christopher [1 ]
Spencer, Erin [2 ]
Dyson, Gregory [3 ]
Ali-Fehmi, Rouba [2 ]
Winer, Ira [3 ]
Cote, Michele [3 ]
Morris, Robert [4 ]
Wallbillich, John [3 ]
机构：
[1] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA
[2] Wayne State Univ, Sch Med, Northville, MI USA
[3] Wayne State Univ, Karmanos Canc Inst, Wayne, NJ USA
[4] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
243
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [1] UTERINE SEROUS CARCINOMA IS MORE AGGRESSIVE THAN HIGH-GRADE SEROUS OVARIAN CARCINOMA: A RETROSPECTIVE STUDY
    Nagano, H.
    Tachibana, Y.
    Kawakami, M.
    Ueno, M.
    Morita, Y.
    Muraoka, M.
    Takagi, K.
    Fujibayashi, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1115 - 1115
  • [2] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
    Robert L. Hollis
    Ian Croy
    Michael Churchman
    Clare Bartos
    Tzyvia Rye
    Charlie Gourley
    C. Simon Herrington
    British Journal of Cancer, 2022, 127 : 1034 - 1042
  • [3] Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
    Hollis, Robert L.
    Croy, Ian
    Churchman, Michael
    Bartos, Clare
    Rye, Tzyvia
    Gourley, Charlie
    Herrington, C. Simon
    BRITISH JOURNAL OF CANCER, 2022, 127 (06) : 1034 - 1042
  • [4] Improving efficacy of microtubule inhibitors in the treatment of high-grade serous ovarian cancer and ovarian carcinosarcoma.
    Vandenberg, Cassandra J.
    Ho, Gwo-Yaw
    Nesic, Ksenija
    Swisher, Elizabeth M.
    Grimmond, Sean M.
    Wakefield, Matthew J.
    Barker, Holly E.
    Bowtell, David D.
    Scott, Clare L.
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment
    Yalcin, Ibrahim
    Meydanli, Mehmet Mutlu
    Turan, Ahmet Taner
    Taskin, Salih
    Sari, Mustafa Erkan
    Gungor, Tayfun
    Akbayir, Ozgur
    Ayhan, Ali
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (02) : 329 - 337
  • [6] Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment
    Ibrahim Yalcin
    Mehmet Mutlu Meydanli
    Ahmet Taner Turan
    Salih Taskin
    Mustafa Erkan Sari
    Tayfun Gungor
    Ozgur Akbayir
    Ali Ayhan
    International Journal of Clinical Oncology, 2018, 23 : 329 - 337
  • [7] The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
    Katsakhyan, Levon
    Baraban, Ezra G.
    Dumoff, Kimberly L.
    Burger, Robert A.
    Parikh, Rupal
    Cooper, Kumarasen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (02) : 175 - 179
  • [8] Primary site assignment in tubal/ovarian high-grade serous carcinoma
    Gilks, B.
    Singh, N.
    Wilkinson, N.
    McCluggage, G.
    VIRCHOWS ARCHIV, 2014, 465 : S40 - S41
  • [9] Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters
    Westbom-Fremer, Sofia
    Tran, Lena
    Ebbesson, Anna
    de la Fuente, Laura Martin
    Jonsson, Jenny-Maria
    Kannisto, Paivi
    Veerla, Srinivas
    Hedenfalk, Ingrid
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (02)
  • [10] Carcinosarcoma of the ovary: MR and clinical findings compared with high-grade serous carcinoma
    Tsukasa Saida
    Kensaku Mori
    Yumiko Oishi Tanaka
    Masafumi Sakai
    Taishi Amano
    Shunsuke Kikuchi
    Souta Masuoka
    Miki Yoshida
    Tomohiko Masumoto
    Toyomi Satoh
    Manabu Minami
    Japanese Journal of Radiology, 2021, 39 : 357 - 366
12345